DNA topoisomerase II inhibitors are a major class of cancer chemotherapeutics, which are
thought to eliminate cancer cells by inducing DNA double-strand breaks. Here we identify a …

The majority of the human genome does not encode proteins. Many of these noncoding
regions contain important regulatory sequences that control gene expression. To date, most …

The anthracycline doxorubicin (Doxo) and its analogs daunorubicin (Daun), epirubicin (Epi),
and idarubicin (Ida) have been cornerstones of anticancer therapy for nearly five decades. …

MHC class I molecules present peptides from endogenous proteins. Ags can also be
presented when derived from extracellular sources in the form of apoptotic bodies. Cross-…

Purpose Tissue-specific drug uptake has not been well studied, compared to the deeper
understanding of drug resistance mediated by the cellular efflux system such as MDR1 proteins. …

Background Induction therapy for acute myeloid leukemia (AML) is an anthracycline-based
chemotherapy regimen. However, many patients experience a relapse or exhibit refractory …

Efficacy of chemotherapy in the treatment of distinct malignancies is often hampered by drug
resistance arising in the tumor. Understanding the molecular basis of drug resistance and …

Cell type- and differentiation-specific gene expression is precisely controlled by genomic
non-coding regulatory elements (NCREs), which include promoters, enhancers, silencers and …

Immune cells are usually considered non-attached blood cells, which would exclude the
formation of gap junctions. This is a misconception since many immune cells express connexin …

The topoisomerase II poisons doxorubicin and etoposide constitute longstanding cornerstones
of chemotherapy. Despite their extensive clinical use, many patients do not respond to …